CINECA IRIS Institutional Research Information System

DE SIMONE, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.865
AS - Asia 15.974
EU - Europa 8.228
SA - Sud America 3.729
AF - Africa 625
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 18
Totale 55.462
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.873
SG - Singapore 5.080
CN - Cina 3.781
HK - Hong Kong 3.432
BR - Brasile 2.998
IT - Italia 2.418
VN - Vietnam 1.701
BG - Bulgaria 1.318
SE - Svezia 875
CA - Canada 800
DE - Germania 709
RU - Federazione Russa 595
FR - Francia 583
TR - Turchia 467
GB - Regno Unito 459
JP - Giappone 337
AR - Argentina 289
FI - Finlandia 284
IN - India 247
AT - Austria 233
CI - Costa d'Avorio 171
BD - Bangladesh 159
UA - Ucraina 143
SN - Senegal 116
EC - Ecuador 112
PL - Polonia 104
ID - Indonesia 101
IQ - Iraq 101
MX - Messico 99
ES - Italia 97
ZA - Sudafrica 91
CO - Colombia 80
CH - Svizzera 77
KR - Corea 76
NL - Olanda 69
PK - Pakistan 69
PY - Paraguay 61
MA - Marocco 60
SA - Arabia Saudita 57
UZ - Uzbekistan 56
EG - Egitto 52
VE - Venezuela 48
EE - Estonia 47
UY - Uruguay 47
CL - Cile 42
PH - Filippine 41
BE - Belgio 35
PE - Perù 33
TN - Tunisia 30
CZ - Repubblica Ceca 28
KE - Kenya 26
NP - Nepal 24
JO - Giordania 21
MY - Malesia 21
IR - Iran 20
BO - Bolivia 18
IE - Irlanda 18
KZ - Kazakistan 18
AU - Australia 17
LT - Lituania 17
PS - Palestinian Territory 17
RO - Romania 17
AE - Emirati Arabi Uniti 16
DZ - Algeria 16
AZ - Azerbaigian 15
DO - Repubblica Dominicana 14
NG - Nigeria 14
OM - Oman 14
PT - Portogallo 14
RS - Serbia 13
ET - Etiopia 12
JM - Giamaica 12
MD - Moldavia 12
TW - Taiwan 12
AL - Albania 10
HN - Honduras 10
EU - Europa 9
GE - Georgia 9
IL - Israele 9
KG - Kirghizistan 9
TT - Trinidad e Tobago 9
BJ - Benin 8
GR - Grecia 8
LB - Libano 8
PA - Panama 8
TH - Thailandia 8
BH - Bahrain 7
BY - Bielorussia 7
GT - Guatemala 7
HU - Ungheria 7
LK - Sri Lanka 7
BB - Barbados 6
CR - Costa Rica 6
LY - Libia 6
SK - Slovacchia (Repubblica Slovacca) 6
BA - Bosnia-Erzegovina 5
BZ - Belize 5
QA - Qatar 5
SI - Slovenia 5
BN - Brunei Darussalam 4
Totale 55.367
Salva come PNG Salva come JPEG
Città #
Hong Kong 3.404
Woodbridge 2.934
Singapore 2.809
Ashburn 2.803
Houston 2.047
Fairfield 2.021
Dallas 1.673
Sofia 1.314
San Jose 1.244
Chandler 1.063
Shanghai 1.062
Ann Arbor 1.031
Beijing 881
Serra 881
Santa Clara 855
Seattle 843
Princeton 733
New York 721
Wilmington 707
Ottawa 698
Cambridge 689
Boardman 545
Lawrence 490
Medford 460
Ho Chi Minh City 452
Milan 425
Lauterbourg 421
Des Moines 408
Los Angeles 406
Istanbul 325
Tokyo 324
Hanoi 281
Redondo Beach 260
Nanjing 222
Buffalo 217
São Paulo 211
Florence 191
Vienna 187
Munich 177
Abidjan 169
Helsinki 145
Dong Ket 140
Jacksonville 131
London 129
Dearborn 127
Pisa 124
Dakar 115
San Diego 114
Ogden 108
Frankfurt am Main 98
Hefei 97
Rio de Janeiro 90
Warsaw 90
Nanchang 88
Council Bluffs 83
Shenyang 81
Boulder 77
Orem 72
Changsha 68
Izmir 65
Haiphong 62
Hebei 61
Belo Horizonte 60
Redwood City 59
Rome 59
Seoul 59
Brasília 54
Nuremberg 53
Turku 52
Tashkent 49
Chennai 47
Stockholm 46
Paris 45
Porto Alegre 45
Da Nang 44
Chicago 43
Curitiba 43
Grafing 43
Kunming 43
Norwalk 43
Columbus 42
Fuzhou 42
Guangzhou 42
Johannesburg 42
Montevideo 42
Tallinn 42
Bern 41
Guayaquil 39
The Dalles 39
Falls Church 38
Baghdad 36
Casablanca 36
Tianjin 36
Dhaka 35
Jiaxing 35
Biên Hòa 33
Campinas 33
Montreal 33
Phoenix 33
Ribeirão Preto 33
Totale 40.388
Salva come PNG Salva come JPEG
Nome #
Osteopontin in hepatocellular carcinoma: A possible biomarker for diagnosis and follow-up 253
Modification of immunosuppressive therapy as risk factor for complications after liver transplantation. 245
DPP-4 is expressed in human pancreatic beta cells and its direct inhibition improves beta cell function and survival in type 2 diabetes 236
Use of Elderly Donors in Liver Transplantation: A Paired-match Analysis at a Single Center 235
Efficacy and safety of combination therapy with everolimus and sorafenib for recurrence of hepatocellular carcinoma after liver transplantation. 232
The Tuscany model of a regional transplantation service authority: Organizzazione Toscana Trapianti 227
Open-source as an enabling approach for the introduction of artificial intelligence in healthcare 210
Cost analysis of tumor downsizing for hepatocellular carcinoma liver transplant candidates 210
Circulating gamma-glutamyltransferase fractions in cirrhosis 210
Perfusion machines and hepatocellular carcinoma: A good match between a marginal organ and an advanced disease? 209
Functional and survival analysis of isolated human islets 206
Avoiding calcineurin inhibitors in the early post-operative course in high-risk liver transplant recipients: The role of extracorporeal photopheresis 204
Severe liver trauma: the transplant surgeon's perspective. A case report 201
Safety and feasibility of electrochemotherapy in patients with unresectable colorectal liver metastases: A pilot study. 199
Multi-locular thymic cysts after acute pancreatitis in a liver transplant recipient 197
Lymphoepithelioma-like hepatocellular carcinoma: Case report and review of the literature 196
Increased FNDC5/Irisin expression in human hepatocellular carcinoma. 196
Persistent or Transient Human β Cell Dysfunction Induced by Metabolic Stress: Specific Signatures and Shared Gene Expression with Type 2 Diabetes 192
Dual aortic and portal perfusion at procurement prevents ischaemic-type biliary lesions in liver transplantation when using octogenarian donors: a retrospective cohort study. 190
Adie tonic pupil associated to endometriosis 189
Anti-inflammatory Signaling During Ex Vivo Liver Perfusion Improves the Preservation of Pig Liver Grafts Before Transplantation 188
Aortic valve-sparing procedure—a durable choice in liver transplantation recipient 188
FAILURE OF ENDOSCOPY FOR NONANASTOMOTIC BILIARY STRICTURES AFTER LIVER TRANSPLANTATION 187
Ex vivo efficacy demonstration of a laser fenestration system for endovascular abdominal aortic aneurysm repair (EVAR) 187
Posttransplant hepatocellular carcinoma metastasis at a skull trauma site 185
Nurses' knowledge and application of evidence-based guidelines for preventing ventilator-associated pneumonia 185
Perfusion machines and hepatocellular carcinoma: a good match between a marginal organ and an advanced disease? 185
ENDOSCOPIC MANAGEMENT OF POST-LIVER TRANSPLANT BILIARY COMPLICATIONS: OUTCOME ANALYSIS OF 751 PROCEDURES 185
Cerium oxide nanoparticles administration during machine perfusion of discarded human livers: A pilot study 184
Evaluation of an uncalibrated arterial pulse contour cardiac output monitoring system in cirrhotic patients undergoing liver surgery 183
Multi-layer nanoencapsulation of human pancreatic islets 183
The impact of everolimus on renal function in maintenance liver transplantation 182
Practice patterns to improve pre and post-transplant medication adherence in heart transplant centres: a secondary data analysis of the international BRIGHT study. 182
Transjugular intrahepatic portosystemic shunt for hepatitis C virus-related portal hypertension after liver transplantation. 179
MULTIPLE CRANIAL NERVE PALSIES IN TESTICULAR LYMPHOMA: REPORT OF A CASE 179
COMMON POLYMORPHISM IN THE MCP-1 GENE REGULATORY REGION INFLUENCES MCP-1 EXPRESSION AND FUNCTION OF ISOLATED TYPE 2 PANCREATIC ISLETS 178
Interregional allocation models for liver transplantation 178
The quality assurance program of organ donation in Tuscany 174
The epidemiology of brain death in Tuscany: is there need for novel indicators? 174
Salvage of an octogenarian liver graft using normothermic perfusion. A case report 174
Heart transplant centers with multidisciplinary team show a higher level of chronic illness management - Findings from the International BRIGHT Study. 173
Quality assurance, efficiency indicators and cost-utility of the evaluation workup for liver transplantation 172
Esofagomiotomia laparoscopica nel trattamento dell’acalasia esofagea. 172
Aging with a Liver Graft: Analysis of Very Long-Term Survivors after Liver Transplantation 172
Avoiding calcineurin inhibitors in the early post-operative course in high-risk liver transplant recipients: Preliminary results of the protect trial 170
A single-staggered dose of calcineurin inhibitor may be associated with neurotoxicity and nephrotoxicity immediately after liver transplantation 169
In situ diode laser fenestration: An ex-vivo evaluation of irradiation effects on human aortic tissue 168
Prevalence of Medication Nonadherence to Co-medication Compared to Immunosuppressants in Heart Transplant Recipients: Findings From the International Cross-sectional BRIGHT Study. 166
2018 Annual Report of the European Liver Transplant Registry (ELTR) - 50-year evolution of liver transplantation 166
AVOIDING CALCINEURIN INHIBITORS IN THE EARLY POST-OPERATIVE COURSE IN HIGH-RISK LIVER TRANSPLANT RECIPIENTS: PRELIMINARY RESULTS OF THE PROTECT TRIAL 165
The "You Are Not Alone" care program for liver transplantation 165
Transplant nursing: scope and standards of practice 165
A common polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene regulatory region influences MCP-1 expression and function of isolated human pancreatic islets 161
Everolimus vs Mycophenolate Mofetil in Combination With Tacrolimus: A Propensity Score-matched Analysis in Liver Transplantation 161
An Unexpected Case of Opisthorchis felineus Infection Revealed during Liver Transplantation 159
AVOIDING CALINEURIN INHIBITORS IN THE EARLY POST OPERATIVE COURSE IN HIGH RISK LIVER TRANSPLANT RECIPIENTS: PRELIMINARY RESULTS OF THE PROTECT TRIAL 159
A selective policy of tumor down staging helps improve the results of liver transplantation for HCC patients within the Milan criteria 159
Post-transplant liver graft schistosomiasis in a migrant from sub-saharan africa. 157
Nonagenarian Grafts for Liver Transplantation 156
Liver transplantation in Jehovah's witnesses: 13 consecutive cases at a single institution 155
A non-meld based allocation algorithm for HCC patients undergoing liver transplantation allows favorable results: The Tuscany experience 154
Involvement of the receptor for advanced glycation end products in liver transplantation 153
Extended criteria grafts and emerging therapeutics strategy in liver transplantation. The unstable balance between damage and repair 153
Aminopyrine breath test in cirrhotic patients awaiting liver transplantation: do we really need it ? 152
Atypical acute leukemia early after liver transplantation 152
Risk analysis of ischemic-type biliary lesions after liver transplant using octogenarian donors 151
Current management of hepatobiliary malignancies between centers with or without a liver transplant program: A multi-society national survey 150
Strategies to optimize the use of marginal donors in liver transplantation. 150
What is the role of the receptor for advanced glycation endproducts-ligand axis in liver injury? 149
EVEROLIMUS-BASED IMMUNOSUPPRESSION IS ASSOCIATED WITH A REDUCED RISK OF NEW- ONSET MALIGNANCIES AFTER LIVER TRANSPLANTATION 149
Combined or staged liver transplantation and duodeno-pancreasectomy: Indications,complications and expansion of wait list criteria 149
Cost-Effectiveness Of Everolimus Plus Reduced Tacrolimus In De Novo Liver-Recipients In The Italian Setting. 148
COVID-19 infection requires strengthening of the chronic care model: the impact on liver transplant practice at a high-volume center in Italy 148
Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study) 148
Refusal to donate after brain death 147
THE PARADOX OF ORGAN SHORTAGE AND EQUITY: HOW TO SOLVE THE RIDDLE ? 146
null 146
7-T MRI of explanted liver and ex-vivo pancreatic specimens: prospective study protocol of radiological-pathological correlation feasibility (the EXLIPSE project) 146
Locoregional treatments for bridging and downstaging hcc to liver transplantation 146
The international prevalence and variability of nonadherence to the nonpharmacologic treatment regimen after heart transplantation: Findings from the cross-sectional BRIGHT study. 145
Efficiency of the Tissue Procurement Process: What Evaluation Tools? 142
Modified RECIST to assess tumor response after transarterial chemoembolization of hepatocellular carcinoma: CT-pathologic correlation in 178 liver explants. 142
Assessment of RANKL/RANK/osteoprotegerin system expression in patients with hepatocellular carcinoma 142
Switch to tacrolimus for cyclosporine-induced gynecomastia in liver transplant recipients 141
Successful Transplant of a Nonagenarian Liver Graft With Fully Replaced Right Hepatic Artery Reconstruction. 141
Lower level of care adversely impacts the outcome of liver transplantation 141
1315-P: Pre– and Post–Liver Transplant Diabetes (DM) and Prediabetes (PD), and the Impact on Transplant Outcomes—Results of a Large Single-Center Study 140
Patient satisfaction among liver transplant recipients: single-center survey. 140
A model for southern mediterranean research institute self-assessment: A SWOT analysis-based approach to promote capacity building at Theodor Bilharz Research Institute in Cairo (Egypt 140
Preliminary Analysis of the Impact of COVID-19 Outbreak on Italian Liver Transplant Programs. 140
A common polymorphism in the MCP-1 gene regulatory regioninfluences MCP-1 expression and function of isolated Type 2 pancreatic islets 139
Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria--selection parameter for liver transplantation 138
The organizational model of the interregional transplant agency Organizzazione Centro-Sud Trapianti. 138
Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study 137
Liver transplantation in type III von Willebrand disease 136
Liver transplantation with aged donors in patients with hepatitis C virus: Authors' reply 135
Immunoadsorption with protein A in humoral rejection of kidney transplants. 135
A model for Southern Mediterranean research institute self-assessment: a SWOT analysis-based approach to promote capacity building at Theodor Bilharz Research Institute in Cairo (Egypt). 135
A NOVEL APPROACH TO ALLOGRAFT REJECTION IN LIVER TRANSPLANT PATIENTS: EXTRACORPOREAL PHOTOPHERESIS 134
Donor diabetes and prolonged cold ischemia time increase the risk of graft failure after liver transplant: Should we need a redefinition of the donor risk index? 133
Totale 16.918
Salva come PNG Salva come JPEG
Categoria #
all - tutte 165.534
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 165.534
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021886 0 0 0 0 0 0 0 0 0 0 385 501
2021/20224.746 39 341 65 207 940 691 99 236 244 110 170 1.604
2022/20233.794 648 451 219 276 393 511 40 266 650 21 279 40
2023/20243.162 229 335 273 204 500 583 126 91 134 57 133 497
2024/202512.775 86 584 103 790 760 1.109 1.170 931 1.458 1.972 1.440 2.372
2025/202615.768 642 1.926 2.524 2.492 1.424 1.487 1.970 652 987 1.247 417 0
Totale 55.997